Prepared by Shane Barclay

Slides:



Advertisements
Similar presentations
Lecture:10 Contractility, Stroke volume and Heart Failure
Advertisements

Dr Bronwyn Avard, July 2010  To understand the basic physiology of shock  To understand the pharmacodynamics and pharmacokinetics of vasoactive drugs.
Congestive Heart Failure and Pulmonary Edema
 Heart failure is a complex clinical syndrome Can result from:  structural or functional cardiac disorder  impairs the ability of the ventricle to.
Congestive heart failure
Pathophysiology of CHF. CHF What is CHF? Fix the underlying problem Heart is a 2 sided pump Both sides can fail independent of each other.
HEART FAILURE “pump failure”. DEFINITION Heart failure is the inability of the heart to supply adequate blood flow and therefore oxygen delivery.
Pharmacology DOR 101 Abdelkader Ashour, Ph.D. 9 th Lecture.
Cardiogenic Shock and Hemodynamics. Outline Overview of shock – Hemodynamic Parameters – PA catheter, complications – Differentiating Types of Shock Cardiogenic.
1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –
MODULE F – HEMODYNAMIC MONITORING. Topics to be Covered Cardiac Output Determinants of Stroke Volume Hemodynamic Measurements Pulmonary Artery Catheterization.
Prepared by : Nehad J. Ahmed.  Heart failure, also known as congestive heart failure (CHF), means your heart can't pump enough blood to meet your body's.
Heart Failure Dr. Meg-angela Christi M. Amores. The term "cardiac failure" means simply failure of the heart to pump enough blood to satisfy the needs.
ANGINA MYOCARDIAL INFARCTION HEART BLOCK CONGESTIVE HEART FAILURE DISORDERS OF THE HEART.
CLARA AND SARAH Shock. Learning Outcomes  Define shock  List the categories of shock  Explain the physiological consequences of shock  Compare physiological.
Heart Failure Karen Ruffin RN, MSN Ed..
Cardiovascular management
CONCEPTS OF NORMAL HEMODYNAMICS AND SHOCK
PHARMAKOLOGY VASOPRESSOR DRUGS DJUDJUK RAHMAD BASUKI Lab.Anestesi dan Terapi Intensive RSSA Malang.
Vasoactive Drugs and Shock
 By the end of this lecture the students are expected to:  Understand the concept of preload and afterload.  Determine factors affecting the end-diastolic.
Copyright ©2010 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. Understanding EKGs: A Practical Approach, Third Edition.
2009 Pandemic Education Package Pharmacology Review.
Chapter 16 Assessment of Hemodynamic Pressures
Heart failure Dr Rafat Mosalli. Objectives Definition Definition Pathophysiology Pathophysiology Age specific Causes Age specific Causes Clinical pictures.
Frank-Starling Mechanism
Congestive Heart Failure ADOPTED FROM: Jarrod Eddy, PGY2 Internal Medicine Sub-I Lecture Series ADOPTED FROM: Jarrod Eddy, PGY2 Internal Medicine Sub-I.
Nursing and heart failure
Cardiovascular Physiology { Function }
PICU Resident Talk Stanford School of Medicine Pediatric Critical Care Medicine June 2014.
Inferior/Right Ventricular Infarction CLINICAL PRESENTATION AND TREATMENT Lady Minto Hospital Emergency Rounds February 2015 Prepared by Shane Barclay.
As part of Lady Minto Hospital Emergency Rounds and All Day Emergency Simulation Workshop Saturday November 14, 2016 Prepared by Shane Barclay UNDIFFERENTIATED.
Copyright 2008 Society of Critical Care Medicine
Diagnosis and Management of Shock Dr. Anas Khan Consultant, EM MBBS, MHA, ArBEM.
Systolic Versus Diastolic Failure. Forms of Heart Failure Sytolic Failure Inability of the ventricle to contract normally and expel sufficient blood Inadequate.
Vasopressors in shock Diane J Lum, PharmD, BCACP Stony Brook University Hospital 9/30/15 1.
Cardiac Emergencies Aaron J. Katz, AEMT-P, CIC
Common Cardiovascular Anomalies and Diseases Heart Attack: This is a vascular disease of the heart characterized by inadequate blood supply to heart muscle.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
 Introduction  Classification of inotropes  Postoperative myocardial dysfunction.  Choice of inotrope  Indications in specific settings.
The cardiovascular system in action 1/Cardiac function and cardiac output 2/ Cardiac cycle.
– Dr. J. Satish Kumar, MD, Department of Basic & Medical Sciences, AUST General Medicine CVS Name:________________________________________ Congestive Heart.
Internal Medicine Workshop Series Laos September /October 2009
Heart Failure Cardiac Insufficiency. What is Heart Failure? Heart failure is a progressive disorder in which damage to the heart causes weakening of the.
Overview of Receptors and Drugs
 By the end of this lecture the students are expected to:  Explain how cardiac contractility affect stroke volume.  Calculate CO using Fick’s principle.
CARDIOVASCULAR MODULE: CARDIAC FAILURE Adult Medical-Surgical Nursing.
PRESSORS & ANTIHYPERTENSIVES Luis R. Sauceda-Cerda, MD PGY-4.
Use of Vasopressors and Ionotropes UCI Internal Medicine Mini Lecture Series June 2014.
Objectives  Understand the vasopressor and inotropic agent receptor physiology  Understand appropriate clinical application of vasopressors and inotropic.
Vasopressors and Inotropes Critical Care Lecture Series.
LMH Emergency Rounds May 23, 2017 Prepared by Shane Barclay MD
ACUTE PULMONARY EDEMA.
Dyspnoea III – Pulmonary oedema
Drug acting on the Heart
Heart Failure - Summary
Congestive heart failure
Acute Heart Failure Treat underlying arrhythmias, etiologies
LMH ER Rounds Prepared by Shane Barclay
ER Drugs and their cardiovascular effects
Undifferentiated Shock diagnosis and management
2 Cardiovascular Physiology: Function.
Characteristics of Adrenergic Drugs (p. 291)
What is the relative risk reduction of ACEi’s/beta blockers for HFrEF?
Diagnosis and Management of shock
Inferior/Right Ventricular Infarction
Naloxone (Narcan) Induced Pulmonary Edema
ຊັອກ (SHOCK).
Recent advances – levosimendan
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
Presentation transcript:

Prepared by Shane Barclay Acute Pulmonary Edema Prepared by Shane Barclay

Acute Pulmonary Edema Two Variations 1. Acute Pulmonary edema with adequate perfusion. Patients usually hypertensive. 2. Acute Pulmonary edema with inadequate perfusion ie cardiogenic shock. Patient’s BP usually low or ‘normal’.

The ‘Old Way’ Traditionally the thought was that CHF was simply extra fluid in the lungs from cardiac decompensation. Treatment of CHF was to give a ton of Lasix IV, then some morphine to ‘open up’ the airways and relax the patient. If they were hypotensive you could use dopamine in low doses to ‘renodilate’ the renal arteries, then give Dobutamine to increase the blood pressure and once that happened then give a ton of Lasix and some morphine. That view has all changed.

Mechanism of CHF/Acute Pulmonary Edema It is now felt that in APE the lungs develop some fluid due to a variety of causes – acute A fib, MI, PE, pneumonia etc. When that happens the body/brain senses fluid in the lungs and the response is that “I am drowning”. This in turn causes a huge catecholamine release – ‘fight or flight response’, which causes massive peripheral vasoconstriction. The vasoconstriction in turn causes more resistance for the heart, which in turn can cause more fluid building up in the lungs and so goes the cycle.

Mechanism of CHF/Acute Pulmonary Edema So now the treatment is to splint the alveoli open to help clear the lungs. This is done with non invasive ventilation and the use of PEEP. This buys you time! Then Nitroglycerin can be given to peripherally dilate the arteries which in turn reduces the afterload. Finally you can give ‘anxiolytics’ usually in the form of Fentanyl to help take away some of the catecholamine surge. As a result, most patients with APE can improve within minutes of having NIV applied.

Treatment of APE The treatment of APE depends on cardiovascular status. Is the patient hemodynamically stable or not? If not, they are usually in “Left Heart Failure”. Left heart failure can be either: - Systolic heart failure - Diastolic heart failure

Types of Heart Failure Systolic and Diastolic Failure Heart failure with reduced ejection fraction, is called systolic failure: The left ventricle loses its ability to contract normally. The heart can't pump with enough force to push enough blood into circulation. Heart failure with preserved ejection fraction, is called diastolic failure (or diastolic dysfunction): The left ventricle loses its ability to relax normally (because the muscle has become stiff). The heart can't properly fill with blood during the resting period between each beat.

Types of Heart Failure Just for completeness there is also Right Sided Heart Failure Right-sided or right ventricular (RV) heart failure usually occurs as a result of left-sided failure. When the left ventricle fails, increased fluid pressure is, in effect, transferred back through the lungs, ultimately damaging the heart's right side. When the right side loses pumping power, blood backs up causing edema and even ascites.

Treatment of APE

Treatment of APE involves Non invasive ventilation Treatment of APE involves Non invasive ventilation. If you are unfamiliar with NIV, it is advised you view the page on REMSTARBC.ca entitled “Ventilators in the ER”

IF Adequate Perfusion (i.e. systolic BP > 100 mmHg, MAP >65) Often these patients are very hypertensive. 1. Oxygen only if hypoxic (most are!), IVs and monitor. 2. Position patient upright (they will want to sit upright!) 3. Non-invasive positive pressure ventilation (NIPPV), start PEEP 6-8, quickly titrate up to 10-12 cm H20. 4. Search for causes (ACS, HTN, arrhythmia, acute aortic or mitral valve regurgitation, aortic dissection, sepsis, renal failure or anemia) and treat appropriately. 5. Intubate ONLY if apneic/agonal respirations.

IF Adequate Perfusion (i.e. systolic BP > 100 mmHg, MAP >65) 6. Vasodilators – Nitroglycerin S/L x 4 sprays, then IV infusion starting at 40 mcg/min, quickly increase by 40-50 mcg/min q 2-4 min up to 200 – 400 mcg/min. 7. If Pt in extremis, bolus Nitro loading dose of 400mcg/min q 2 min up to 5 doses, then drop to 100 mcg/min. Titrate up prn. 8. +/- ACE Inhibitor – sublingual Captopril 12.5 – 25 mg

IF Hypotensive (decompensated CHF) (systolic BP < 100) 1. Oxygen, IVs and monitor. 2. Most of these Pts are complex, call ICU or internist! 3.Provide non-invasive positive pressure ventilation (NIPPV) unless immediate intubation is needed. 4. Search for causes (ACS, HTN, arrhythmia, acute aortic or mitral valve regurgitation, aortic dissection, sepsis, renal failure or anemia) and treat appropriately. 5. Consider Fluid challenge, 250 cc N/S over 5 minutes.

IF Hypotensive (decompensated CHF) (systolic BP < 100) 6. If known systolic heart failure - -Use Inotrope: Dobutamine 2 mcg/Kg/min and increase to a max. 20 mcg/Kg/min. 7. If known diastolic heart failure with signs of hypotension/shock – - Use IV Vasopressor - Phenylephrine 0.5mcg/kg/min and titrate. (NOT inotrope) 8. If unknown cardiac status and signs of hypotension/shock – -Use Inotrope – Dobutamine 2 mcg/Kg/min and titrate up. 9. Once BP restored, then you can add IV Nitroglycerin.

Back to basic pharmacology Why Dobutamine? versus norepinephrine or dopamine or … Any why not a ‘pressor’ for diastolic heart failure?

b1 b1 b1 Drug a1 Inotr Chron Dromo b2 V/C V/D Phenylephrine +++ Epinephrine ++ +++ ++ ++ ++ Norepinephrine +++ ++ ++ ++ + Isoproterenol ++ ++ ++ Dobutamine ++ ++ +

Dobutamine the cardiac ‘squeeze’ drug Has positive inotropic (beta agonist) properties but very little/no vasoconstrictive properties (alpha agonist) Main use is in Cardiogenic Shock (Systolic heart failure) Dose: Start 2 mcg/kg/min

Dobutamine

Dobutamine for Systolic Failure In APE you already have maximal peripheral vasoconstriction, so you don’t want to add another vasoconstrictor. Dobutamine has no alpha adrenergic properties, so it won’t exacerbate peripheral vasoconstriction. Rather it will assist in cardiac inotropic and chronotropic activity to help restore cardiac function.

Phenylephrine for Diastolic Failure In diastolic heart failure, the left ventricle can not relax and becomes ‘stiff’. Adding a beta adrenergic inotrope will only exacerbate this condition. Instead you want to add an alpha agonist (ie phenylephrine) to cause vasoconstriction and therefore increase systemic blood pressure without ‘taxing’ the heart even more.

Systolic and Diastolic Failure If you are interested, the next two slides are You Tube videos explaining more of the systolic versus diastolic heart failure pathophysiology.

Case 1 EHS calls saying 72 year old woman with SOB Vitals: BP 190/110 HR 180/min Sats 82% Resp Rate 35/min Will be arriving in 2 minutes.

Mrs. Heidi Whetlung 78 year old woman with increasing SOB Began with ‘flu’ 3 days ago. History of HTN, RA, Diverticulosis, depression. Medication: Ramipril 2.5 mg od HCTZ 12.5 mg od Quinine 200 mg hs Tylenol ES tid Mirtazapine 15 mg daily

Mrs. Heidi Whetlung

What are you going to do?

Case 2 EHS has brought in a 66 year old female, Noreen Rhales, with acute SOB. Vitals BP 96/40 HR 170 RR 40 Sats 90% on 10 liters by mask.

Ms. Noreen Rhales Increasing SOB for 2 days Felt “unwell”, lethargic for 2 days, noted ‘palpitations’. Awaiting “valve replacement surgery” in 8 weeks Has been in CHF twice in past year. Meds: Ramipril 5 mg bid, Metoprolol 25 mg bid, Lasix 20 mg od, Aldactone 50 mg od, ASA 81 mg od, Synthroid 125 mcg od, Naprosyn 500 bid,

Ms. Noreen Rhales Exam: BP 90/50, HR 170, RR 38, Sats 90%, Looks terrified, can’t speak more than 2 words without gasping for breath. Course creps heard up to upper lung fields.

What are you going to do?

The END